KLOW – TB-500 10mg / BPC-157 10mg / KPV 10mg / GHK-Cu 50mg

 189,00

KLOW Peptide Blend containing BPC-157, GHK-Cu, KPV and TB-500 80 mg – Grail Formula Quality. Researched and verified with Liquilabs s.r.o. Czechia. Analytical validation confirms assay contents BPC-157 11.36 mg, GHK-Cu 51.2 mg, KPV 10.09 mg and TB-500 10.58 mg. Endotoxin detected but below 0.01 EU per mg, with no detectable heavy metals or microbial contamination. Supplied as an 80 mg lyophilized multi-peptide blend with full COA traceability. Within Europe this product is supplied including bacteriostatic water; outside the EU only the peptide vial is provided. For research use only — not for human or veterinary use.

Availability: In stock: ships within 1 day after payment confirmation.

Within Europe this product is supplied including bacteriostatic water; outside Europe only the peptide vial is provided. For research use only – not for human or veterinary use.   Product Overview The KLOW Peptide Blend combines four research peptides: BPC-157, GHK-Cu, KPV and TB-500 (Thymosin Beta 4). This 80 mg formulation is designed for controlled laboratory investigation of multi-pathway biochemical interactions involving repair pathways, cellular signalling and immunomodulatory models. Each component is lyophilized with independently verified purity, identity and assay content.   Peptide Overview Between 2015 and 2025 blended peptide systems gained increasing interest due to their multi-mechanistic modelling potential. The KLOW blend provides a defined ratio of four highly purified peptides enabling reproducible in-vitro studies on combined signalling behaviour and biochemical response patterns. Each peptide contributes to separate but complementary research pathways.   Historical Background and Scientific Context Scientific focus on repair-associated peptides, copper-binding peptides and anti-inflammatory tripeptides expanded significantly over the past decade. Blended laboratory systems were evaluated for their ability to model multi-step biochemical interactions. The KLOW blend has been analytically validated to support structured pathway-modelling and combined mechanistic research.   Mechanistic Focus in Research
  • BPC-157: modelling tissue-repair pathways and cellular migration
  • GHK-Cu: copper-dependent biochemical signalling studies
  • KPV: inflammatory-pathway and immunological response modelling
  • TB-500: cytoskeletal and repair-associated biochemical modelling
  • Combined mechanistic pathway evaluation under controlled conditions
  Analytical Verification (COA) Independent Liquilabs analysis confirms full validation for Batch GF092025044. Key results include:
  • BPC-157 Assay Content: 11.36 mg
  • GHK-Cu Assay Content: 51.2 mg
  • KPV Assay Content: 10.09 mg
  • TB-500 Assay Content: 10.58 mg
  • Endotoxins: detected but below 0.01 EU per mg
  • Microbial Growth: not detected for aerobic count, yeast or mold
  • Heavy Metals: not detected including arsenic, cadmium, cobalt, lead, nickel, mercury and vanadium
All analytical results were obtained using validated chromatographic, spectroscopic and microbiological procedures ensuring transparent documentation and complete traceability.   Research Applications
  • Multi-pathway biochemical modelling
  • Repair and recovery pathway evaluation
  • Immunological and anti-inflammatory response studies
  • Copper-peptide signalling and cellular regulation modelling
  • Controlled in-vitro multi-component experiments
 

Grail Formula Quality

Every Grail Formula research peptide undergoes independent laboratory testing for purity, identity, structural integrity and microbial safety. All batches are verified for stability, low endotoxin levels and reproducibility to ensure reliable scientific outcomes.

When You Choose Grail Formula…

Researchers receive fully documented peptides with batch-number traceability, sealed-vial integrity and transparent laboratory verification. EU shipments include sterile bacteriostatic water; outside the EU only the peptide vial is supplied.

Used solely for in vitro experiments and cannot be:

  • Used in clinical trials involving humans
  • Administered to humans as part of an experiment or investigation
  • Supplied to another party for human investigational use
  • Verified and analysed with Liquilabs s.r.o. Czechia
  • Includes BPC-157, GHK-Cu, KPV and TB-500 in defined assay ratios
  • Purity and identity independently validated for all components
  • Endotoxin level below 0.01 EU per mg
  • No detectable heavy metals or microbial contamination
  • Batch GF092025044 – Published November 2025
  • EU shipments include bacteriostatic water
  • For research use only – not for human or veterinary use

For laboratory research only. Not intended for human consumption, injection, or cosmetic use.

This product is for research purposes only. Not for human use or diagnostic/therapeutic applications. Keep out of reach of children.

Related Products